292 related articles for article (PubMed ID: 30324219)
1. Awakening the "guardian of genome": reactivation of mutant p53.
Binayke A; Mishra S; Suman P; Das S; Chander H
Cancer Chemother Pharmacol; 2019 Jan; 83(1):1-15. PubMed ID: 30324219
[TBL] [Abstract][Full Text] [Related]
2. Mutant p53 reactivation by small molecules makes its way to the clinic.
Bykov VJ; Wiman KG
FEBS Lett; 2014 Aug; 588(16):2622-7. PubMed ID: 24768524
[TBL] [Abstract][Full Text] [Related]
3. Recent Synthetic Approaches towards Small Molecule Reactivators of p53.
Silva JL; Lima CGS; Rangel LP; Ferretti GDS; Pauli FP; Ribeiro RCB; da Silva TB; da Silva FC; Ferreira VF
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32326087
[TBL] [Abstract][Full Text] [Related]
4. Reactivation of mutant p53 by capsaicin, the major constituent of peppers.
Garufi A; Pistritto G; Cirone M; D'Orazi G
J Exp Clin Cancer Res; 2016 Sep; 35(1):136. PubMed ID: 27599722
[TBL] [Abstract][Full Text] [Related]
5. Small molecule compounds targeting the p53 pathway: are we finally making progress?
Yu X; Narayanan S; Vazquez A; Carpizo DR
Apoptosis; 2014 Jul; 19(7):1055-68. PubMed ID: 24756955
[TBL] [Abstract][Full Text] [Related]
6. Targeting mutant p53 for efficient cancer therapy.
Bykov VJN; Eriksson SE; Bianchi J; Wiman KG
Nat Rev Cancer; 2018 Feb; 18(2):89-102. PubMed ID: 29242642
[TBL] [Abstract][Full Text] [Related]
7. A balancing act: using small molecules for therapeutic intervention of the p53 pathway in cancer.
Miller JJ; Gaiddon C; Storr T
Chem Soc Rev; 2020 Oct; 49(19):6995-7014. PubMed ID: 32869798
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological activation of p53 in cancer cells.
Athar M; Elmets CA; Kopelovich L
Curr Pharm Des; 2011; 17(6):631-9. PubMed ID: 21391904
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of mutant p53: molecular mechanisms and therapeutic potential.
Selivanova G; Wiman KG
Oncogene; 2007 Apr; 26(15):2243-54. PubMed ID: 17401433
[TBL] [Abstract][Full Text] [Related]
10. New therapeutic strategies to treat human cancers expressing mutant p53 proteins.
Blandino G; Di Agostino S
J Exp Clin Cancer Res; 2018 Feb; 37(1):30. PubMed ID: 29448954
[TBL] [Abstract][Full Text] [Related]
11. How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance.
Stiewe T; Haran TE
Drug Resist Updat; 2018 May; 38():27-43. PubMed ID: 29857816
[TBL] [Abstract][Full Text] [Related]
12. Reactivating mutant p53 using small molecules as zinc metallochaperones: awakening a sleeping giant in cancer.
Blanden AR; Yu X; Loh SN; Levine AJ; Carpizo DR
Drug Discov Today; 2015 Nov; 20(11):1391-7. PubMed ID: 26205328
[TBL] [Abstract][Full Text] [Related]
13. Wild type p53 reactivation: from lab bench to clinic.
Selivanova G
FEBS Lett; 2014 Aug; 588(16):2628-38. PubMed ID: 24726725
[TBL] [Abstract][Full Text] [Related]
14. The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer.
Farnebo M; Bykov VJ; Wiman KG
Biochem Biophys Res Commun; 2010 May; 396(1):85-9. PubMed ID: 20494116
[TBL] [Abstract][Full Text] [Related]
15. Salvation of the fallen angel: Reactivating mutant p53.
Li Y; Wang Z; Chen Y; Petersen RB; Zheng L; Huang K
Br J Pharmacol; 2019 Apr; 176(7):817-831. PubMed ID: 30632144
[TBL] [Abstract][Full Text] [Related]
16. Targeting Y220C mutated p53 by Foeniculum vulgare-derived phytochemicals as cancer therapeutics.
Garg S; Singh J; Verma SR
J Mol Model; 2023 Jan; 29(2):55. PubMed ID: 36700982
[TBL] [Abstract][Full Text] [Related]
17. p53 activation by blocking Snail: a novel pharmacological strategy for cancer.
Lee SH; Park BJ
Curr Pharm Des; 2011; 17(6):610-7. PubMed ID: 21391911
[TBL] [Abstract][Full Text] [Related]
18. Small molecule agents targeting the p53-MDM2 pathway for cancer therapy.
Wang W; Hu Y
Med Res Rev; 2012 Nov; 32(6):1159-96. PubMed ID: 23059763
[TBL] [Abstract][Full Text] [Related]
19. Chaperoning the guardian of the genome. The two-faced role of molecular chaperones in p53 tumor suppressor action.
Wawrzynow B; Zylicz A; Zylicz M
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):161-174. PubMed ID: 29355591
[TBL] [Abstract][Full Text] [Related]
20. [Advances on mutant p53 research].
Li DH; Zhang LQ; He FC
Yi Chuan; 2008 Jun; 30(6):697-703. PubMed ID: 18550490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]